Friedreich Ataxia Scientific News

Friedreich Ataxia and close related scientific news. Topics related to rare diseases.

Thursday, November 14, 2013

Gene therapy for Friedreich’s ataxia based on the modification of viral and non-viral vectors to improve their delivery across the blood brain barrier.

›
Research Project Gene therapy for Friedreich’s ataxia based on the modification of viral and non-viral vectors to improve their d...
Tuesday, November 12, 2013

Frataxin directly stimulates mitochondrial cysteine desulfurase by exposing substrate-binding sites and a mutant Fe-S cluster scaffold protein with frataxin-bypassing ability acts similarly

›
Frataxin directly stimulates mitochondrial cysteine desulfurase by exposing substrate-binding sites and a mutant Fe-S cluster scaffold prote...
Monday, November 11, 2013

Mitochondrial metals as a potential therapeutic target in neurodegeneration

›
Mitochondrial metals as a potential therapeutic target in neurodegeneration . A Grubman, A R White, J R Liddell; British Journal of Pharmac...
Friday, November 8, 2013

Exclusive: 'Jaw-dropping' breakthrough hailed as landmark in fight against hereditary diseases as Crispr technique heralds genetic revolution

›
Exclusive: 'Jaw-dropping' breakthrough hailed as landmark in fight against hereditary diseases as Crispr technique heralds genetic r...
Thursday, November 7, 2013

Ataxia: Physical Therapy and Rehabilitation Applications for Ataxic Patients

›
Ataxia: Physical Therapy and Rehabilitation Applications for Ataxic Patients . Armutlu K. 2013; JH Stone, M Blouin, editors. International ...
Tuesday, November 5, 2013

Edison Pharmaceuticals, FARA, and USF Announce Initiation of EPI-743 Phase 2 Friedreich's Ataxia Clinical Trial in Adults with Point Mutations

›
Edison Pharmaceuticals, FARA, and USF Announce Initiation of EPI-743 Phase 2 Friedreich's Ataxia Clinical Trial in Adults with Point Mut...
Monday, November 4, 2013

4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES

›
4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES . Patent, EDISON PHARMACEUTICALS INC [US Methods of...
Saturday, November 2, 2013

Project: Investigating the neuroprotective and neuroregenerative properties of bone marrow stem cell mobilising drugs in Friedreich ataxia.

›
Project: Investigating the neuroprotective and neuroregenerative properties of bone marrow stem cell mobilising drugs in Friedreich ataxia. ...

Mössbauer Study and Modeling of Iron Import and Trafficking in Human Jurkat Cells

›
Mössbauer Study and Modeling of Iron Import and Trafficking in Human Jurkat Cells . Nema D. Jhurry, Mrinmoy Chakrabarti, Sean P. McCormick, ...

Clinical features and progression of cardiomyopathy in patients with Friedreich's ataxia

›
Clinical features and progression of cardiomyopathy in patients with Friedreich's ataxia . Vincent Pureza, Linda Hasadsri, W. Edward Hig...
‹
›
Home
View web version

About Me

My photo
Juan Carlos Baiges
Tortosa, Catalunya, Spain
BSc, MSc (Pharmacy), MSc (Computer science)
View my complete profile
Powered by Blogger.